Change - Announcement of Cessation::RESIGNATION OF CHIEF EXECUTIVE OFFICER

Issuer & Securities

Issuer/ Manager
SINGAPORE O&G LTD.
Securities
SINGAPORE O&G LTD. - SG1DG2000005 - 1D8
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
30-Jan-2018 17:19:41
Status
New
Announcement Sub Title
RESIGNATION OF CHIEF EXECUTIVE OFFICER
Announcement Reference
SG180130OTHRYDTW
Submitted By (Co./ Ind. Name)
Dr. Heng Tung Lan
Designation
Executive Chairman
Description (Please provide a detailed description of the event in the box below)
This Announcement has been prepared by the Company and its content have been reviewed by the Company's sponsor, Hong Leong Finance Limited (the "Sponsor"), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the "SGX-ST"). The Sponsor has not independently verified the contents of this Announcement. This Announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this Announcement including the correctness of any of the statements or opinions made or reports contained in this Announcement.

The contact person for the Sponsor is Mr. Tang Yeng Yuen, Vice-President, Head of Corporate Finance, at 16 Raffles Quay, #01-05 Hong Leong Building, Singapore 048581. Telephone number: (65) 6415 9886.

Additional Details

Name Of Person
DR. NG KOON KENG
Age
57
Is effective date of cessation known?
Yes
If yes, please provide the date
31/01/2018
Detailed Reason (s) for cessation
To pursue other interests. Based on its enquiries, the Company's Sponsor, Hong Leong Finance Limited, is satisfied that, save as disclosed in this announcement, there are no other material reasons for the cessation of Dr. Ng Koon Keng ("Dr. Ng") as the Chief Executive Officer of Singapore O&G Ltd.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
26/04/2012
Does the AC have a minimum of 3 members (taking into account this cessation)?
No
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
1
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Executive Officer.
Role and responsibilities
Dr. Ng is responsible for the overall administration, operations and business development, marketing and management of the Group.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
N/A
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
In own name: 6,439,590
DBS Nominees: 8,000,000
Total shareholdings: 14,439,590 (3.0%)
Past (for the last 5 years)
Singapore O&G Group
- None

Other Companies
- None
Present
Singapore O&G Group*
- Beh's Clinic for Women Pte. Ltd.
- Choo Wan Ling Women's Clinic Pte. Ltd.
- Heng Clinic for Women Pte. Ltd.
- KW Lee Clinic & Surgery for Women Pte. Ltd.
- SOG-Cindy Pang Clinic for Women Pte. Ltd.
- SOG-Radhika Breast & General Surgicare Pte. Ltd.
- SOG Dermatology Pte. Ltd.
- SOG-SC Hong Clinic for Women Pte. Ltd.
- SOG-SK Lim Breast & General Surgicare Pte. Ltd.
- SOG-Natalie Chua Clinic for Women Pte. Ltd.
- SOG Children (Paediatrics-Central) Pte. Ltd.

Other Companies
- None

* As part of his role as CEO, Dr. Ng was appointed as the director of these subsidiaries of the Company. Following his cessation, Dr. Ng has tendered his resignation as director of these subsidiaries of the Company.